Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/28/2003WO2002006833A3 Improved non-luminescent substrate
08/28/2003WO2002002823A3 Polynucleotide sequence assay
08/28/2003WO2002002780A3 Human serine-threonine kinase
08/28/2003WO2002000938A3 Methods and compositions for transcription-based nucleic acid amplification
08/28/2003WO2001097098A3 Computational molecular docking methods for assessing complementarity of combinatorial libraries to biotargets
08/28/2003WO2001096875A3 Hcv antigen/antibody combination assay
08/28/2003WO2001081924A3 Reusable microarrays for quantifying low abundance proteins
08/28/2003WO2001069257A9 Device for in situ analysis and/or treatment with flexible rod
08/28/2003WO2001069257A3 Device for in situ analysis and/or treatment with flexible rod
08/28/2003WO2001063241A9 Microfluidic devices and methods
08/28/2003US20030163276 Process for controlling the temperature of wastewater samples
08/28/2003US20030163259 Method and apparatus for quantifying progress of sample clean up with curve fitting
08/28/2003US20030163049 Method and system for characterization and mapping of tissue lesions
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162947 Rapid production of monoclonal antibodies
08/28/2003US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162942 Binding to ligand; adjustment of pH; elution
08/28/2003US20030162826 Degradation fragments
08/28/2003US20030162761 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor
08/28/2003US20030162727 Use of cyp1b1inhibitors for treating cancer
08/28/2003US20030162717 Suppression appetite; weight loss therapy
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162692 Follicle stimulating hormone stimulated genes and uses thereof
08/28/2003US20030162308 Orthogonal read assembly
08/28/2003US20030162305 Catalytic oxidation of hydrocarbons; for compact, transportable analysis
08/28/2003US20030162303 Zero headspace extractor and method for determining partitioning and contaminant release rates of volatile and semi-volatile compounds
08/28/2003US20030162301 Luminescent spectroscopic anlaysis
08/28/2003US20030162297 Method for assaying the antioxidant capacity of a sample
08/28/2003US20030162284 Comprises permeable micromatrices which encapsulate test compounds; high-throughput assay; drug screening
08/28/2003US20030162278 Use for development of human therapeutic proteins; amino acid sequences, allelic variants, isolated polypeptide, antibody and nucleic acids, transgenic non-human animal, culturing the host cell, genetic engineering
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/28/2003US20030162247 32164 protein, a novel seven transmembrane protein
08/28/2003US20030162242 Method of selectively determining glycated hemoglobin
08/28/2003US20030162239 Total cysteine assay
08/28/2003US20030162236 Corrected analyte-binding particle amount is determined as a ratio of the amount of analyte-binding particles in the sample capture zone, to the amount of analyte-binding particles in control capture zone
08/28/2003US20030162235 Reaction detecting method, immune reaction detecting method and apparatus therefor
08/28/2003US20030162234 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
08/28/2003US20030162233 Method for purifying cancer-specific proliferating cell nuclear antigen
08/28/2003US20030162231 Alzheimer's disease; antiagglomerant of amyloid deposits
08/28/2003US20030162230 Measurement phosphorylation of protein
08/28/2003US20030162229 Immuno-interactive fragments of the alpha-C subunit of inhibin
08/28/2003US20030162228 Prevent binding between various transforming growth factors
08/28/2003US20030162226 High speed screening; resolution of enantiomorphs by crystallization; bioavailability
08/28/2003US20030162224 Characterization of molecules
08/28/2003US20030162223 Detection of insecticide; determination, calibration of binding to protein
08/28/2003US20030162221 Complexing, immunoprecipitation, analyzing
08/28/2003US20030162219 Methods for predicting functional and structural properties of polypeptides using sequence models
08/28/2003US20030162218 High-throughput screening of expressed DNA libraries in filamentous fungi
08/28/2003US20030162217 Method of identifying nucleic acids
08/28/2003US20030162216 Nucleic acid ligand diagnostic biochip
08/28/2003US20030162215 Using semiconductor nanoparticles; biopolymer labeled with avidin, biotin
08/28/2003US20030162213 Terminal-phosphate-labeled nucleotides and methods of use
08/28/2003US20030162209 PCR based high throughput polypeptide screening
08/28/2003US20030162204 Alcohol detection assembly
08/28/2003US20030162197 Method of detecting neoplastic or non-neoplastic cells
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162194 Diagnosis of diseases associated with apoptosis
08/28/2003US20030162192 Polymorphisms associated with ion-channel disease
08/28/2003US20030162190 Immobilized nucleotide aptamer
08/28/2003US20030162185 Products comprising a support to which nucleic acids are fixed and their use as dna chips
08/28/2003US20030162184 Amplification; polymerase chain reactions
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030162167 Hepatitis c virusl detection using Dna sequences; liver disorders; immunoassay
08/28/2003US20030162165 Chemical signal enhancement of dynamic intensity-based intracellular protein-and fluorophore-based redistribution assays for drug-screening
08/28/2003US20030162164 Comparative phenotype analysis of cells, including testing of biologically active compounds
08/28/2003US20030161918 Treating with silica and vacuum steam deordorizing in the presence of rosemary or sage extract
08/28/2003US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases
08/28/2003US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/28/2003US20030161832 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen
08/28/2003US20030161788 System for monitoring bacterial tumor treatment
08/28/2003US20030161787 Calibration using teleost alevin; measuring heart function
08/28/2003US20030161760 Collection well for body fluid tester
08/28/2003US20030160958 Measuring method for immunochromatographic test strip
08/28/2003US20030160182 Apparatus and method for detecting fecal and ingesta contamination using a hand held illumination and imaging device
08/28/2003US20030160174 Method and apparatus for real-time monitoring of furnace flue gases
08/28/2003US20030160155 Device having touch sensitivity functionality
08/28/2003US20030160151 Imaging fluorometer for time resolved fluorescence
08/28/2003US20030159946 Electrochemical sensing
08/28/2003US20030159945 Electrolytic cells; liquid sample
08/28/2003US20030159944 Disposable electrolytic cells; quantitative analysis
08/28/2003US20030159932 Method and apparatus for analysing low concentrations of particles
08/28/2003US20030159929 Sensor for helium or hydrogen
08/28/2003US20030159927 Colloidal particles used in sensing arrays
08/28/2003US20030159641 Method and equipment for producing biopolymer crystal
08/28/2003US20030159531 Measuring physical properties of sample
08/28/2003US20030159527 Sample flow path assembly for electronic gas leak detectors
08/28/2003US20030159495 High flow rate sample flow path assembly for electronic gas leak detectors
08/28/2003CA2513192A1 Nucleotide sequence coding for a tolc and a defined amino acid sequence
08/28/2003CA2508550A1 A urine sample collection device
08/28/2003CA2487395A1 Method for discovering pharmacologically active substances
08/28/2003CA2486388A1 Novel fungal lipase
08/28/2003CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
08/28/2003CA2477159A1 Highly homogeneous molecular markers for electrophoresis
08/28/2003CA2477096A1 Materials and methods relating to cancer diagnosis
08/28/2003CA2477021A1 Methods and apparatuses for characterizing stability of biological molecules
08/28/2003CA2477012A1 Anti-a.beta. antibodies and their use
08/28/2003CA2476965A1 Method of modulating e-cadherin mediated cell adhesion
1 ... 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 ... 3937